“…In the last two decades, the interest in organoselenium biochemistry and pharmacology has increased due to a variety of compounds that show biological activity (May, 1999;Nogueira et al, 2004, Nogueira & Rocha, 2011. In fact, its compounds show antioxidant (Gerzson et al, 2012;Luchese et al, 2009;Nogueira et al, 2004;Prigol et al, 2009), neuroprotective (Porciúncula et al, 2003), antidepressant-like (Gerzson et al, 2012;Oliveira et al, 2012;Savegnago et al, 2008), antihypertensive, anticancer, antiviral, immunosuppressive, and antimicrobial properties (May, 1999;Nogueira et al, 2004;Schewe, 1995). Recently, our group of research showed hepatoprotective effect of bis(4-methylbenzoyl) diselenide (BMD), an disubstituted diaryl diselenide, against carbon tetrachloride (CCl 4 )-induced oxidative damage in mice possibly by modulating the antioxidant status (Filho et al, 2013).…”